Learning Objectives:

• List the three phases of the U.S. Food and Drug Administration (FDA) new drug approval process.
• Describe challenges in engaging people with HIV in clinical trials.
• Discuss strategies for recruiting people with HIV in HIV-related clinical trials.

Jaspreet Banga, MD, MPH, is a board-certified Infectious Diseases physician currently working at Rutgers-New Jersey Medical School. She is also an investigator in the NIH-funded clinical trials unit for HIV prevention and treatment.

Dr. Banga has a deep passion for providing care to disproportionately affected communities and a special interest in advancing representation in clinical trials.